Zota Health Care LImited

Web: zotahealthcare.com NSE: ZOTA SECTOR: Healthcare - Pharmaceuticals & Biotechnology

1300 22(2%)

Volume

2L as on 23, Jun

Open

819

High

859

Low

810

1,277

VWAP

1,380

52 Week High

1,740

52 Week Low

1,026

Viand Research Rating

Quality Score

27/100

Growth Score

50/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

4,502

No. of Shares

3.46

P/E

P/B

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

ROCE

Profit Growth

Listing Date

19-Aug-19

Promoter Holding

49.38%

FII Holding

8.21%

DII Holding

6.4%

Price Chart

Price Performance

1 Week13%

1 Month15%

3 Months32%

6 Months17%

1 Year17%

YTD17%

Moving Average

5 Day SMA1,310

10 Day SMA1,265

20 Day SMA1,221

30 Day SMA1,213

50 Day SMA1,250

61 Day SMA1,227

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	1,485	1,393	1,431	1,526
Resistance 2	1,431	1,385	1,399	1,451
Resistance 1	1,400	1,377	1,379	1,440
Pivot Point	1,346	1,369	1,346	1,366
Support 1	1,315	1,362	1,314	1,356
Support 2	1,261	1,354	1,294	1,281
Support 3	1,230	1,346	1,261	1,270

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,099	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,792	7300	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,70,907	5050	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,264	8851	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,12,694	1395	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,10,623	1109	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,686	2399	3%	3%	11%	25%	23	57.7	0.29	5355
8	MANKIND	1,05,603	2557	0%	0%	18%	3%	49	57.7	0.39	1938
9	MAXHEALTH	1,05,114	1080	2%	1%	8%	14%	0	57.7	0.32	1442
10	DRREDDY	97,638	1170	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Apr 2025	Mar 2025	Feb 2025	Dec 2024	Sep 2024	Aug 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(-1.31) 49.38%	(-5.21) 50.64%	(-1.61) 55.81%	(-0.71) 57.42%	(-1.61) 58.11%	(0.01) 59.72%	(-2.31) 59.72%	(-0.41) 62.02%	(0.01) 62.40%	(-2.01) 62.40%	(-1.71) 64.44%	(0.01) 66.15%	(0.01) 66.15%	(-2.01) 66.16%	(0.01) 68.12%	(0.01) 68.12%	(0.01) 68.12%	(0.01) 68.12%	(0.01) 68.12%	(0.01) 68.11%	(0.01) 68.09%
FIIs	(0.11) 8.21%	(4.61) 8.09%	(-0.31) 3.49%	(0.21) 3.82%	(2.71) 3.60%	(-0.21) 0.87%	(0.81) 1.02%	(0.21) 0.24%	(0.01) 0.01%	(0.01) 0.02%	(0.01) 0.01%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.02%	(0.01) 0.04%	(0.01) 0.00%	(-0.11) 0.00%	(0.11) 0.07%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
DIIs	(-0.81) 6.40%	(2.31) 7.22%	(0.71) 4.95%	(1.31) 4.25%	(-0.21) 2.92%	(0.01) 3.08%	(2.11) 3.08%	(0.01) 1.03%	(0.21) 0.99%	(0.81) 0.76%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(-0.11) 0.00%	(-0.41) 0.05%	(0.21) 0.45%	(0.01) 0.30%	(0.01) 0.34%
Public	36.00%	34.06%	35.75%	34.52%	35.38%	36.33%	36.18%	36.71%	36.60%	36.82%	35.55%	33.85%	33.85%	33.83%	31.84%	31.88%	31.88%	31.75%	31.43%	31.59%	31.57%
No. of Shareholders	14,005	13,185	11,855	10,354	10,382	10,389	10,324	9,763	8,937	9,369	7,661	7,435	7,589	7,285	7,107	7,233	7,956	7,866	8,149	7,817	7,255

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	163	143	129	104	97	72	67	56	50	47	45	39	37	35	39	29	31	31	35	33
Sales Growth % (YoY)	68%	98%	92%	84%	96%	54%	49%	46%	35%	34%	16%	32%	18%	13%	10%	-13%	2%	2%	25.6%	90.5%
Sales Growth % (QoQ)	14%	10.9%	24%	7.2%	34.7%	7.5%	19.6%	12%	6.4%	4.4%	15.4%	5.4%	5.7%	-10.3%	34.5%	-6.5%	-	-11.4%	6.1%	-
Expenses	154	143	123	100	95	78	68	58	51	44	41	37	36	35	34	28	31	26	31	29
Operating Profit	9	0	6	4	2	-6	-1	-1	-1	3	4	1	1	0	5	1	0	5	5	5
OPM %	5	0	5	4	3	-8	-1	-2	-3	7	10	3	3	0	12	5	0	16	14	15
Other Income	-3	2	2	1	1	1	1	0	0	0	0	0	1	1	1	0	1	0	0	0
Interest	5	5	4	3	3	2	3	3	2	1	1	1	1	1	1	0	0	0	0	0
Depreciation	27	22	19	15	14	11	10	8	7	5	5	3	4	3	3	2	2	1	1	1
Profit before tax	-26	-26	-14	-13	-14	-18	-13	-12	-10	-3	-1	-3	-3	-3	2	0	-1	5	4	5
Tax %	-45	14	13	5	-10	2	-4	5	-27	7	49	1	-15	-4	58	119	1	26	26	26
Net Profit	-14	-30	-16	-14	-13	-19	-12	-13	-7	-3	-2	-3	-3	-3	1	-1	-1	3	3	3
Net Profit Growth % (QoQ)	53.3%	-87.5%	-14.3%	-7.7%	31.6%	-58.3%	7.7%	-85.7%	-133.3%	-50%	33.3%	-	-	-400%	200%	-	-133.3%	-	-	-
Net Profit Growth % (YoY)	-7.7%	-57.9%	-33.3%	-7.7%	-85.7%	-533.3%	-500%	-333.3%	-133.3%	-	-300%	-200%	-200%	-200%	-66.7%	-133.3%	-	-	-	-
TTM Net Profit	-74	-73	-62	-58	-57	-51	-35	-25	-15	-11	-11	-8	-6	-4	2	4	8	9	6	0
EPS in Rs	-4.09	-8.73	-5.2	-4.81	-4.5	-6.78	-4.41	-4.79	-2.68	-1.14	-0.64	-1.13	-1.05	-1.28	0.36	-0.33	-0.4	1.33	1.28	1.37

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2015	Mar 2014	Mar 2012	Mar 2011
Sales	539	292	180	139	131	106	95	85	56	50	38	25
Sales Growth %	85%	62%	29%	7%	23%	12%	11%	-	13%	-	52%	-
Expenses	520	298	173	132	116	105	90	77	47	43	33	21
Operating Profit	19	-6	8	7	15	1	5	8	8	6	5	4
OPM %	3	-2	4	5	11	1	5	9	15	13	13	14
Other Income	1	2	1	2	2	2	2	2	0	0	0	0
Interest	17	11	5	3	0	0	0	0	1	1	1	0
Depreciation	82	43	20	12	4	3	2	1	2	1	1	0
Profit before tax	-80	-58	-16	-5	12	0	4	8	6	5	3	3
Tax %	-7	-2	-11	23	28	-41	29	29	33	33	33	34
Net Profit	-74	-57	-14	-6	9	0	3	6	4	3	2	2
Net Profit Growth %	-29.8%	-307.1%	-133.3%	-166.7%	-	-100%	-50%	50%	33.3%	50%	-	-
EPS in Rs	-21.35	-19.7	-5.55	-2.29	3.54	-0.09	1.12	2.26	2.12	1.85	1.43	2.17
Dividend Payout %	-5	-5	-18	-44	42	-1170	90	32	34	38	50	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2015	Mar 2014
Cash from Operating Activity	-84	-50	-6	-2	13	-1	6	-3	5	3
Cash from Investing Activity	-314	-92	-13	15	-27	4	-4	9	-1	-1
Cash from Financing Activity	490	145	19	-14	14	-2	-3	-6	-4	-2
Net Cash Flow	92	3	0	-1	1	1	-1	-1	0	0

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2015	Mar 2014	Mar 2012	Mar 2011
Equity Capital	35	31	29	27	26	25	25	25	25	18	14	12	10	7
Reserves	659	285	195	132	64	55	64	42	44	51	4	4	3	5
Borrowings	270	181	140	107	95	45	15	0	0	0	5	5	6	3
Other Liabilities	167	109	76	51	43	33	35	19	20	21	17	14	10	5
Total Liabilities	1131	606	439	317	228	158	139	85	88	90	40	35	29	20
Fixed Assets	383	251	185	137	103	62	29	14	15	10	8	9	10	8
CWIP	2	7	6	5	5	3	0	0	0	2	0	0	0	0
Investments	264	92	54	44	5	8	33	10	14	16	0	0	0	0
Other Assets	483	256	193	130	116	85	77	61	59	63	32	26	19	12
Total Assets	1131	606	439	317	228	158	139	85	88	90	40	35	29	20

Delivery

#	Date	1100 34% 1478	Value (Cr)	Q/T 21	Del 57	Del 7
1	22-Jul	1277	10	15	64	7
2	21-Jul	1331	3	11	52	1
3	20-Jul	1331	4	10	55	2
4	17-Jul	1350	4	11	56	3
5	16-Jul	1370	3	12	55	2
6	15-Jul	1365	6	15	59	4
7	14-Jul	1386	7	17	77	5
8	13-Jul	1437	12	13	52	6
9	10-Jul	1423	14	17	51	7
10	9-Jul	1418	9	16	56	5
11	8-Jul	1413	11	13	41	5
12	7-Jul	1402	7	25	79	6
13	6-Jul	1421	6	10	56	3
14	3-Jul	1445	8	20	53	4
15	2-Jul	1438	7	19	58	4
16	1-Jul	1431	12	16	46	5
17	30-Jun	1417	15	18	54	8
18	29-Jun	1396	20	20	63	13
19	25-Jun	1390	14	21	64	9
20	24-Jun	1385	13	18	55	7
21	23-Jun	1376	23	21	58	13
22	22-Jun	1369	16	17	66	10
23	19-Jun	1308	22	17	57	13
24	18-Jun	1274	13	21	47	6
25	17-Jun	1221	3	14	57	2
26	16-Jun	1220	4	13	67	3
27	15-Jun	1247	7	17	66	4
28	12-Jun	1225	8	18	63	5
29	11-Jun	1197	5	14	60	3
30	10-Jun	1214	3	13	50	1
31	9-Jun	1211	6	32	80	5
32	8-Jun	1204	8	26	70	6
33	5-Jun	1260	19	21	35	7
34	4-Jun	1186	5	17	70	4
35	3-Jun	1226	16	25	61	10
36	2-Jun	1143	12	31	53	6
37	1-Jun	1125	3	17	53	1
38	29-May	1125	4	20	57	2
39	27-May	1121	8	22	68	6
40	26-May	1172	7	19	57	4
41	25-May	1122	14	24	56	8
42	22-May	1193	3	20	68	2
43	21-May	1216	1	13	52	1
44	20-May	1203	1	11	57	1
45	19-May	1205	3	16	60	2
46	18-May	1200	4	22	54	2
47	15-May	1208	2	16	64	1
48	14-May	1203	2	11	50	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	4,502c	93c	2.11
22-Jul	4,409c	225c	4.86
21-Jul	4,634c	69c	1.47
17-Jul	4,703c	87c	1.81
16-Jul	4,790c	35c	0.74
15-Jul	4,754c	145c	2.95
14-Jul	4,899c	85c	1.71
13-Jul	4,984c	78c	1.58
10-Jul	4,907c	17c	0.34
09-Jul	4,890c	4c	0.07
08-Jul	4,894c	16c	0.33
07-Jul	4,878c	30c	0.61
06-Jul	4,907c	89c	1.78
02-Jul	4,996c	34c	0.68
01-Jul	4,963c	35c	0.71
30-Jun	4,928c	52c	1.07
29-Jun	4,876c	68c	1.40
26-Jun	4,808c	23c	0.47
25-Jun	4,831c	49c	1.01
24-Jun	4,783c	21c	0.44
23-Jun	4,762c	7c	0.15
22-Jun	4,769c	294c	6.58
19-Jun	4,475c	232c	5.47
17-Jun	4,243c	31c	0.74
16-Jun	4,211c	106c	2.46
15-Jun	4,318c	92c	2.18
12-Jun	4,226c	69c	1.60
11-Jun	4,294c	96c	2.29
10-Jun	4,198c	0	0

Stock Checklist

Price is below from 52 week high low average: 23%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 4 fund scheme(s) across 1 fund house(s) as of Jul26 · Total value ₹28 Cr · 0 increasing / 4 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
WhiteOak Capital Mutual Fund	4	0.59%	-0.14%	28.5

Zota Health Care LImited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements